<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.4: Caffeine: Ergogenic Effects and Individual Sensitivity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/ORANGE theme for Sports Nutrition */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #3b82f6;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f8f9fa;
            padding: 15px;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #d1d5db;
            margin-top: 40px;
        }

        .takeaways-box .box-label {
            color: #1e3a8a;
            font-weight: 700;
            text-transform: uppercase;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 12px;
            border: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #666;
            font-size: 16px;
            border-bottom: 1px solid #eee;
            padding-bottom: 10px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            color: #777;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: Evidence-Based Supplementation</p>
            <h1 class="lesson-title">Lesson 6.4: Caffeine: Ergogenic Effects and Individual Sensitivity</h1>
            <div class="lesson-meta">
                <span class="meta-item">28 min read</span>
                <span class="meta-item">Lesson 4 of 10</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Mechanisms of Action</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Performance Benefits</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Dosing & Timing Protocols</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Genetic Variability (CYP1A2)</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Habituation & Withdrawal</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Safety & Practical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Deconstruct the physiological mechanism of caffeine as an adenosine receptor antagonist.</li>
                <li>Evaluate the ergogenic impact of caffeine across aerobic, anaerobic, and cognitive domains.</li>
                <li>Design individualized caffeine protocols based on body mass and exercise timing.</li>
                <li>Analyze how the CYP1A2 genotype influences caffeine metabolism and performance outcomes.</li>
                <li>Manage habituation, withdrawal, and potential side effects in high-performance athletes.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Gold Standard of Ergogenics</h3>
            <p>Within the <strong>F.U.E.L.E.D. Performance Framework‚Ñ¢</strong>, caffeine sits at the pinnacle of the 'E' (Ergogenic Optimization). It is perhaps the most researched and widely utilized legal performance enhancer in existence. Unlike many supplements that offer marginal gains, caffeine provides a robust, reproducible effect on physical and cognitive performance. However, its "one-size-fits-all" reputation is a myth; as a coach, you must navigate the complex landscape of genetic metabolism and individual sensitivity to maximize its benefits while avoiding the pitfalls of overstimulation.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Adenosine Antagonism</p>
                    <p class="definition">The primary mechanism where caffeine binds to adenosine receptors, blocking the "sleepiness" signal and increasing neural firing.</p>
                </div>
                <div class="term-item">
                    <p class="term">CYP1A2 Enzyme</p>
                    <p class="definition">The liver enzyme responsible for metabolizing ~95% of caffeine. Genetic variations determine if an athlete is a "fast" or "slow" metabolizer.</p>
                </div>
                <div class="term-item">
                    <p class="term">RPE (Rate of Perceived Exertion)</p>
                    <p class="definition">A subjective measure of how hard an athlete feels they are working; caffeine significantly lowers this during exercise.</p>
                </div>
                <div class="term-item">
                    <p class="term">Pharmacokinetics</p>
                    <p class="definition">The study of how the body processes a substance, including absorption, distribution, metabolism, and excretion.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">Mechanisms of Action</h2>
        <p>Caffeine (1,3,7-trimethylxanthine) is a central nervous system (CNS) stimulant that crosses the blood-brain barrier with ease. While it was once thought that caffeine‚Äôs primary benefit was through increased fat oxidation (sparing glycogen), we now know its ergogenic effects are predominantly <span class="highlight">neurological</span>.</p>

        <p>The most critical mechanism is <strong>Adenosine Antagonism</strong>. Adenosine is a byproduct of ATP breakdown that accumulates in the brain throughout the day, binding to receptors to signal fatigue and downregulate CNS activity. Caffeine is structurally similar to adenosine and binds to these receptors (specifically A1 and A2a) without activating them. This prevents adenosine from exerting its inhibitory effects, leading to increased levels of dopamine, norepinephrine, and glutamate.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">99%</div>
                    <div class="stat-label">Absorption Rate</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">45m</div>
                    <div class="stat-label">Peak Blood Conc.</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">5-7h</div>
                    <div class="stat-label">Average Half-Life</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">~6%</div>
                    <div class="stat-label">RPE Reduction</div>
                </div>
            </div>
        </div>

        <p>Beyond the brain, caffeine enhances <strong>neuromuscular function</strong> by increasing the release of calcium from the sarcoplasmic reticulum and improving the sensitivity of myofilaments to calcium. This results in more forceful muscle contractions and improved motor unit recruitment.</p>

        <h2 id="section2">Performance Benefits</h2>
        <p>Caffeine's benefits are broad, but the magnitude of the effect varies by the type of exertion. A 2019 umbrella review of 21 meta-analyses found that caffeine has a significant ergogenic effect on virtually all forms of exercise tested.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Performance Metric</th>
                        <th>Typical Improvement</th>
                        <th>Evidence Strength</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Aerobic Endurance</td>
                        <td>2.0% ‚Äì 4.0%</td>
                        <td>Very High</td>
                    </tr>
                    <tr>
                        <td>Muscle Strength (1RM)</td>
                        <td>2.0% ‚Äì 3.0%</td>
                        <td>Moderate-High</td>
                    </tr>
                    <tr>
                        <td>Muscle Endurance</td>
                        <td>6.0% ‚Äì 7.0%</td>
                        <td>High</td>
                    </tr>
                    <tr>
                        <td>Anaerobic Power (Sprints)</td>
                        <td>1.0% ‚Äì 3.0%</td>
                        <td>Moderate</td>
                    </tr>
                    <tr>
                        <td>Cognitive Function (Fatigued)</td>
                        <td>Significant (Reaction Time)</td>
                        <td>High</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>In endurance sports, the reduction in <span class="highlight">Rate of Perceived Exertion (RPE)</span> is the game-changer. Athletes can maintain a higher power output or pace for the same level of perceived effort. In strength sports, the benefit is often seen in the later sets of a workout, where caffeine helps maintain volume and intensity despite accumulating fatigue.</p>

        <h2 id="section3">Dosing & Timing Protocols</h2>
        <p>To optimize the 'E' in the F.U.E.L.E.D. framework, dosing must be precise. The current scientific consensus for ergogenic benefit is <strong>3‚Äì6 mg per kilogram of body mass (mg/kg)</strong>.</p>

        <div class="principle-card">
            <div class="principle-title">Dosing Guidelines</div>
            <p class="principle-text">For a 70kg (154lb) athlete:</p>
            <ul>
                <li><strong>Low Dose (3 mg/kg):</strong> 210 mg (Approx. 2 strong cups of coffee)</li>
                <li><strong>Moderate Dose (6 mg/kg):</strong> 420 mg (Upper limit for most athletes)</li>
                <li><strong>Timing:</strong> Consume 30‚Äì60 minutes prior to exercise to allow for peak plasma concentration.</li>
            </ul>
        </div>

        <p>It is important to note that <span class="highlight">higher doses (>9 mg/kg)</span> do not typically provide additional performance benefits and significantly increase the risk of side effects such as gastrointestinal distress, tremors, and tachycardia. For some athletes, even doses as low as 1‚Äì2 mg/kg can provide cognitive benefits and RPE reduction without the jitters.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üö¥‚Äç‚ôÇÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: Endurance Optimization</p>
                    <p class="subtitle">Ironman Triathlete Performance</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 34</h4>
                        <p>Endurance Athlete | Body Mass: 75kg</p>
                    </div>
                </div>
                <p><strong>Goal:</strong> Improve 40km Time Trial performance without GI distress.</p>
                <p><strong>Intervention:</strong> Marcus previously used 200mg (2.6 mg/kg) with mild results. We increased his dose to 400mg (5.3 mg/kg) via anhydrous caffeine pills 45 minutes pre-race. We also added 50mg "top-offs" every 90 minutes during his long training rides to maintain plasma levels.</p>
                <p><strong>Outcome:</strong> Marcus reported a 3.2% improvement in average power output. His RPE at 300W dropped from 17 (Very Hard) to 15 (Hard). No GI issues were reported because we used anhydrous caffeine rather than acidic coffee.</p>
            </div>
        </div>

        <h2 id="section4">Genetic Variability (CYP1A2)</h2>
        <p>Why does one athlete feel "on fire" after a cup of coffee while another feels anxious or sees no benefit? The answer lies in the <strong>CYP1A2 gene</strong>, which encodes the enzyme responsible for caffeine metabolism.</p>

        <p>Research led by Guest et al. (2018) highlighted that the <strong>AA genotype</strong> (Fast Metabolizers) sees the most significant ergogenic benefits. Conversely, those with the <strong>CC genotype</strong> (Slow Metabolizers) may actually experience a <em>decrease</em> in performance when using high doses of caffeine, likely due to prolonged vasoconstriction or sustained anxiety levels.</p>

        <div class="comparison-grid">
            <div class="comparison-card functional">
                <p class="card-label">Fast Metabolizers (AA)</p>
                <p class="card-text">Clear ergogenic benefit at 4-6 mg/kg. Rapid clearance (half-life ~3-4 hours). Minimal sleep disruption if taken in the morning.</p>
            </div>
            <div class="comparison-card conventional">
                <p class="card-label">Slow Metabolizers (AC/CC)</p>
                <p class="card-text">May experience increased anxiety and heart palpitations. Ergogenic effect is often neutralized or negative. Half-life can exceed 10 hours.</p>
            </div>
        </div>

        <p>In addition to CYP1A2, the <strong>ADORA2A gene</strong> influences sensitivity to caffeine-induced anxiety. Athletes with a high sensitivity should stick to the lower end of the dosing spectrum (1-3 mg/kg) or avoid caffeine entirely if it compromises their technical execution or mental state.</p>

        <h2 id="section5">Habituation & Withdrawal</h2>
        <p>A common question in sports nutrition is whether athletes should "cycle" caffeine to maintain sensitivity. Chronic caffeine consumption leads to an <strong>upregulation of adenosine receptors</strong>, meaning the brain creates more binding sites to compensate for those blocked by caffeine.</p>

        <p>Recent data suggests that while habituation may diminish the "kick" or the acute arousal feeling, the <span class="highlight">ergogenic effect on performance</span> remains largely intact for most athletes. However, the risk of <strong>withdrawal</strong> is real. If an athlete who consumes 500mg daily suddenly stops for a competition, they may suffer from headaches, lethargy, and decreased motivation, which will certainly hurt performance more than the caffeine would have helped.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Tip</p>
            <p>If an athlete wants to maximize the "acute" feeling of caffeine for a major event, a 2-4 day "washout" period or a 50% reduction in habitual intake is usually sufficient to resensitize receptors without triggering severe withdrawal.</p>
        </div>

        <h2 id="section6">Safety & Practical Application</h2>
        <p>As a coach, your priority is the athlete's health and recovery. Caffeine is a double-edged sword; its ability to enhance performance can be completely negated if it destroys sleep quality.</p>

        <p><strong>The Sleep Connection:</strong> Even if an athlete can "fall asleep" after caffeine, the presence of caffeine in the system reduces <strong>Slow Wave Sleep (Deep Sleep)</strong>, which is critical for physical recovery and hormonal regulation. Encourage athletes to avoid caffeine at least 8-10 hours before their intended bedtime.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üèãÔ∏è‚Äç‚ôÄÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: Managing Side Effects</p>
                    <p class="subtitle">Powerlifter with Sleep Issues</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 28</h4>
                        <p>Competitive Powerlifter | Evening Trainer</p>
                    </div>
                </div>
                <p><strong>Challenge:</strong> Sarah trains at 6:00 PM and was taking 400mg of caffeine to "get through" her heavy sessions. She reported insomnia and poor recovery (high HRV morning readings).</p>
                <p><strong>Intervention:</strong> We moved her caffeine intake to 2:00 PM (300mg) and replaced her 6:00 PM pre-workout with a non-stimulant vasodilator (Citrulline Malate). We also introduced 200mg of <strong>L-Theanine</strong> with her afternoon dose to "smooth out" the jitters.</p>
                <p><strong>Outcome:</strong> Sarah's sleep latency dropped from 90 minutes to 15 minutes. Her recovery scores improved, and she maintained her strength levels during evening sessions without the acute stimulant.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of caffeine physiology and application.</p>

            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">What is the primary neurological mechanism by which caffeine reduces fatigue?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Caffeine acts as an adenosine receptor antagonist. It binds to adenosine receptors in the brain, preventing adenosine from signaling fatigue and downregulating the central nervous system.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">An 80kg athlete wants to use a moderate ergogenic dose of caffeine. According to the 3-6mg/kg guideline, what is their target range?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">The target range is 240mg to 480mg. (80kg x 3mg = 240mg; 80kg x 6mg = 480mg).</p>
            </div>

            <div class="question-item">
                <div class="question-number">3</div>
                <p class="question-text">Why might a 'Slow Metabolizer' (CC genotype) perform worse after a high dose of caffeine?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Slow metabolizers have the caffeine in their system for much longer, which can lead to prolonged vasoconstriction (reducing blood flow to muscles) and sustained high levels of anxiety/jitteriness that interfere with coordination and focus.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Mechanism:</strong> Caffeine works primarily through CNS adenosine antagonism and improved neuromuscular calcium handling.</li>
                <li><strong>Standard Dose:</strong> 3‚Äì6 mg/kg of body mass is the "sweet spot" for performance enhancement.</li>
                <li><strong>Timing:</strong> Consume 30‚Äì60 minutes pre-exercise for anhydrous forms; coffee may take slightly longer.</li>
                <li><strong>Genetics Matter:</strong> Use caution with slow metabolizers (CYP1A2 CC genotype), as caffeine may be ergolytic (performance-hindering) for them.</li>
                <li><strong>Recovery Balance:</strong> Always prioritize sleep; caffeine‚Äôs half-life means it can disrupt deep sleep even if taken 6+ hours before bed.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Grgic, J., et al. (2019). "Wake up and smell the coffee: caffeine supplementation and exercise performance‚Äîan umbrella review of 21 published meta-analyses." British Journal of Sports Medicine.</li>
                <li>Guest, N. S., et al. (2018). "Caffeine, CYP1A2 Genotype, and Endurance Performance in Athletes." Medicine & Science in Sports & Exercise.</li>
                <li>Southward, K., et al. (2018). "The Effect of Caffeine Ingestion on Endurance Performance: A Systematic Review and Meta-Analysis." Sports Medicine.</li>
                <li>Burke, L. M. (2008). "Caffeine and sports performance." Applied Physiology, Nutrition, and Metabolism.</li>
                <li>Pickering, C., & Kiely, J. (2018). "Are the Ergogenic Effects of Caffeine Modified by the CYP1A2 Gene? A Systematic Review." Journal of the International Society of Sports Nutrition.</li>
                <li>Spriet, L. L. (2014). "Exercise and Sport Performance with Low Doses of Caffeine." Sports Medicine.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Sports Nutrition Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The F.U.E.L.E.D. Performance Framework‚Ñ¢ is a proprietary methodology.</p>
        </footer>
    </div>
</body>

</html>